RecruitingNCT06858748

Canadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough

Canadian Consortium for Understanding the Role of Airway Mucus Occlusions in Asthma, COPD and Chronic Cough


Sponsor

McMaster University

Enrollment

240 participants

Start Date

Dec 11, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic lung diseases affect one in five Canadians, causing symptoms such as cough, breathlessness, and wheeze. Despite advancements in medical care, these conditions not only impact individuals and their close circles but also present substantial clinical and economic challenges at a national level. This grant is dedicated to addressing three prevalent lung diseases: asthma, chronic obstructive pulmonary disease (COPD), and chronic cough. An alliance of clinicians, scientists, knowledge users, and patient partners from across Canada have come together to establish the Canadian Consortium for Understanding the Role of Airway Mucus Occlusions in Asthma, COPD, and Chronic Cough - "CANMuc." Mucus plays a pivotal role in the symptoms and severity of lung diseases, but its clinical assessment has been challenging. Fortunately, recent medical advances, particularly chest computed tomography (CT), facilitate visualizing and quantifying mucus in patients with lung diseases. Our goal is to initially assess mucus plugging in a diverse group of Canadians without lung disease and then compare these findings to those with asthma, COPD, and chronic cough. The investigators will recruit 100 healthy volunteers for comprehensive clinical and research evaluations, including sputum analyses, breathing tests, quality of life assessments, cough monitoring, and CT scans. In addition, testing will be conducted twice, two years apart, in 240 adult and 50 pediatric participants. This approach will enable the investigators to understand the burden of mucus and how it changes over time, explore proteins or chemicals in mucus that predict mucus persistence, and identify biomarkers that can help guide physicians to prescribe targeted treatments that might work better than others. The CANMuc team's findings will guide strategies for identifying and treating mucus plugging, inform policymakers, and share knowledge with Canadians living with asthma, COPD, and chronic cough.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This Canadian research consortium is studying the role of mucus buildup in the airways of people with asthma, COPD, or chronic cough — looking at how mucus contributes to breathing problems and disease severity, and comparing these findings with healthy individuals. **You may be eligible if...** - You are 18 or older - You have a confirmed diagnosis (from a respiratory specialist) of moderate-to-severe asthma, moderate-to-severe COPD, or refractory/unexplained chronic cough lasting more than 1 year - OR you are a healthy adult with no respiratory history (for the control group) **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are a current smoker or smoked heavily within the past 6 months - You had a respiratory flare-up within the past 4 weeks - You were born prematurely (at or before 36 weeks) - You are currently on biologic therapy for asthma or COPD - You use mucolytic medications or have a suspected rare lung condition called primary ciliary dyskinesia Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational

This is a 24-month observational study in adults in three disease domains, consisting of screening visit, baseline visit, quarterly telemonitoring visit and end of monitoring period


Locations(6)

St. Paul's Hospital

Vancouver, British Columbia, Canada

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, Canada

Robarts Research Institute

London, Ontario, Canada

The Ottawa Hospital

Ottawa, Ontario, Canada

Quebec Heart and Lung Institute - Laval University

Québec, Quebec, Canada

Université de Sherbrooke

Sherbrooke, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06858748


Related Trials